reports
- GlobalData Healthcare Department
KaloBios Pharmaceuticals Inc (KBIO) - Financial Analysis Review
KaloBios Pharmaceuticals Inc (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals Inc (KaloBios) is a development stage biopharmaceutical company that develops medicines for neglected and rare diseases. The company offers benznidazole, a nitroimidazole derivative used for the treatment of Chagas disease, a parasitic infection caused due to protozoan organism called Trypanosoma cruzi. GlobalData's KaloBios Pharmaceuticals Inc (KBIO) - Financial Analysis Review provides a compreh...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.